Tuomas Lasanen - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2020	1
2022	1
2023	1
2024	0

Page 1

The In Vitro Replication, Spread, and Oncolytic Potential of Finnish Circulating Strains of Herpes Simplex Virus Type 1.

Kalke K, Orpana J, Lasanen T, Esparta O, Lund LM, Frejborg F, Vuorinen T, Paavilainen H, Hukkanen V. Kalke K, et al. Among authors: lasanen t. Viruses. 2022 Jun 13;14(6):1290. doi: 10.3390/v14061290. Viruses. 2022. PMID: 35746761 Free PMC article.

Single therapeutic dose of an antiviral UL29 siRNA swarm diminishes symptoms and viral load of mice infected intranasally with HSV-1.

Lasanen T, Frejborg F, Lund LM, Nyman MC, Orpana J, Habib H, Alaollitervo S, Levanova AA, Poranen MM, Hukkanen V, Kalke K. Lasanen T, et al. Smart Med. 2023 May 10;2(2):e20230009. doi: 10.1002/SMMD.20230009. eCollection 2023 May. Smart Med. 2023. PMID: 39188276 Free PMC article.

Herpes Simplex Virus Type 1 Clinical Isolates Respond to UL29-Targeted siRNA Swarm Treatment Independent of Their Acyclovir Sensitivity.

Kalke K, Lehtinen J, Gnjatovic J, Lund LM, Nyman MC, Paavilainen H, Orpana J, Lasanen T, Frejborg F, Levanova AA, Vuorinen T, Poranen MM, Hukkanen V. Kalke K, et al. Among authors: lasanen t. Viruses. 2020 Dec 13;12(12):1434. doi: 10.3390/v12121434. Viruses. 2020. PMID: 33322225 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

3 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year